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Abstract
Rationale Psychopharmacology needs novel quantitative measures and theoretical approaches based on computational
modelling that can be used to help translate behavioural findings from experimental animals to humans, including
patients with neuropsychiatric disorders.
Objectives This brief review exemplifies this approach when applied to recent published studies of the effects of
manipulating central dopaminergic and serotoninergic systems in rodents and marmoset monkeys, and possible
comparisons with healthy human volunteers receiving systemic agents or patients with depression and schizophrenia.
Methods Behavioural effects of central depletions of dopamine or serotonin in monkeys in probabilistic learning
paradigms are characterised further by computational modelling methods and related to rodent and human data.
Results Several examples are provided of the power of computational modelling to derive new measures and reappraise con-
ventional explanations of regional neurotransmitter depletion and other drug effects, whilst enhancing construct validation in
patient groups. Specifically, effects are shown on such parameters as ‘stimulus stickiness’ and ‘side stickiness’, which occur over
and above effects on standard parameters of reinforcement learning, reminiscent of some early innovations in data analysis in
psychopharmacology.
Conclusions Computational modelling provides a useful methodology for further detailed analysis of behavioural
mechanisms that are affected by pharmacological manipulations across species and will aid the translation of exper-
imental findings to understand the therapeutic effects of medications in neuropsychiatric disorders, as well as
facilitating future drug discovery.
Keywords Computer modelling . Reinforcement learning . Dopamine . Serotonin . Depression . Schizophrenia
Psychopharmacology is a quantitative branch of neuroscience
that relates behavioural effects of drugs in the laboratory or the
clinical context to their underlying mechanisms. From the
pharmacological perspective, the ability of the investigator
to vary the dose of the active drug so as to produce graded
behavioural effects provides an exquisite test of the relation-
ship. From the experimental psychologist’s perspective, it is
desirable to seek the most sensitive measures for that relation-
ship, which may involve transforming the dependent variables
in theoretically coherent ways, using computational methods,
to attain insight into controlling processes and mechanisms.
An excellent example is the use of signal detection theory
(Green and Swets 1966) which can dissect discrimination per-
formance into two orthogonal factors—discriminative sensi-
tivity (measured by d’) and response bias (β or c). The latter
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provides an overall tendency to make a particular choice (e.g.
to respond or not, to answer ‘yes’ or ‘no’) which could arise
from response strategy or motivational factors. Warburton and
Brown (1972) introduced such methods into psychopharma-
cology to show that cholinergic agents such as physotigmine,
at least at some doses in rats, improved d’with no effects onβ,
suggesting that the drug enhanced visual attention.
Bernard Weiss and Victor Laties (Weiss and Gott
1972; Laties 1972) also pioneered the use of sophisti-
cated variables to characterise drug effects and several
investigators have employed microanalyses of behaviour
to look for understanding at the level of ongoing se-
quential changes in behaviour. For example, Koek and
Slangen (1984), using a measure of the conditional ten-
dency to repeat responding [p(rep)], found that amphet-
amine had a tendency to increase response repetition
that overshadowed its effects on discrimination per se.
Sahgal and Clincke (1985) pointed out potential prob-
lems with the p(rep) measure and introduced more re-
fined indices that were shown to be sensitive to this
tendency under amphetamine.
Although there is much to be said for examining effects of
drugs on stable baselines of choice behaviour (established, for
example, by training) in order to analyse processes such as
attention, it is also important to quantify effects of drugs on the
dynamic processes of learning—although it is more difficult
and costly to perform adequate dose-response analyses.
Traditionally, learning can be measured crudely in terms of
the number of trials, or errors made, that it takes to reach a
suitable criterion of discrimination. However, reinforcement
learning theory has provided us with a number of algorithms
that adequately support learning, ranging from agent-based
approaches (Russell and Norvig 1995; Sutton and Barto
1998) to more psychologically motivated models such as that
of Rescorla and Wagner (1972) for Pavlovian conditioning.
Learning can be interpreted as a hypothesis testing or environ-
mental modelling process by which the animal (or human)
p r ed i c t s ou t comes o f i t s behav iou r a l cho i ces .
Mechanistically, learning can be driven by ‘prediction errors’
that signal a difference between expected outcomes and ob-
tained outcomes, updating pre-existing evidence of the asso-
ciative strength of a specific response with this new evidence.
Prediction errors can thus be seen as part of the brain’s
Bayesian updating process. Modern computing has also
brought the ability to apply formal Bayesian computational
approaches analytically, providing a rich potential basis for
analysing drug effects on learning. This has become an excit-
ing endeavour, given that we not only understand much about
how drugs such as amphetamine affect neurotransmitter func-
tion, but also because of discoveries that neurotransmitters
such as dopamine (DA) and serotonin (5-hydroxytryptamine,
5-HT) play important roles in learning as well as performance.
Thus, Schultz et al. (1997), based on such previously
hypothesised mechanisms (Montague et al. 1996), were able
to show in rhesus monkeys that the phasic firing of mid-brain
DA neurons in response to conditioned stimuli (CSs) associ-
ated with reward provided the neuronal substrate of prediction
errors. These neurons’ behaviour conformed to classical learn-
ing algorithms, including the Rescorla-Wagner equation,
where learning is essentially represented as:
ΔVCS ¼ αβ λ–V totalð Þ
whereΔVCS represents the change in learned association for a
CS, (λ – Vtotal) represents a mismatch (prediction error) be-
tween expected (Vtotal) and obtained (λ) outcomes, and α and
β are constants for the CS (predictor) and the unconditioned
stimulus (US or outcome), respectively. In the original state-
ment of this learning theory (Rescorla and Wagner 1972, p.
75–76), λ is described as the asymptote of learning on a given
trial, which depends on the US presented and may be 0 for
nonreinforcement. The parameter α is a learning rate associ-
ated with the CS (to capture the concept that different CSs
may have different salience and thus support learning at dif-
ferent rates) and β is a learning rate associated with the US (to
support the assumption that different USs might similarly sup-
port learning at different rates); α and β are constrained to the
range [0, 1] (Box 1).
In humans, prediction errors have been confirmed during
reinforcement learning via the haemodynamic blood-oxygen-
level-dependent functional magnetic resonance imaging
(BOLD fMRI) response. Typical paradigms have used prob-
abilistic discrimination learning in which subjects learn to
choose by trial and error which of two stimuli is more likely
associated with reinforcement when one stimulus on average
is rewarded, for example, on 75% of trials and for the other
stimulus on 25% of trials, with punishment (or non-reward)
occurring on the other trials in reciprocal manner (i.e. 25% and
75% respectively). The initial probabilistic learning phase
may be followed by one ormore reversals of the contingencies
to further assess the flexibility of learning (Fig. 1). Such par-
adigms have revealed activity during learning and reversal in
such structures as the orbitofrontal and ventrolateral prefrontal
cortex and the ventral striatum, which are in receipt of dopa-
minergic afferents (O’Doherty et al. 2001; Cools et al. 2002).
Reinforcement learning theory and dopamine
It is obviously more difficult in human studies to measure the
activity of DA neurons specifically, although it is possible to
employ relatively specific DA agonists and antagonists that
can be used to test the causal validity of the correlation
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betweenDA neuron firing and behaviour. One of the first such
studies (Pessiglione et al. 2006) compared the effects of sys-
temic doses of 3,4-dihydroxy-L-phenylalanine (L-dopa) and
the D2/3 DA receptor antagonist haloperidol, together with a
placebo control, to assess effects of manipulations of DA
function in three separate groups of human volunteers
performing an instrumental probabilistic discrimination
learning paradigm. In this procedure, subjects were rewarded
on 75% of occasions for choosing option A, signalled by a
distinctive visual fractal stimulus, and only 25% for option B,
signalled by a second fractal stimulus (analogous to, but not
the same as, to those shown in Fig. 1). In such a task, the
optimal strategy for maximising rewards is to choose option
A 100% of the time, even though this inevitably results in
Box 1: Selected computational models of simple learning processes
Delta rule for observational learning: Rescorla–Wagner (1972) model of classical conditioning
Delta rule for actions: Q learning in Pessiglione et al. (2006)
Delta rule with “stimulus stickiness” and “side stickiness” (Clarke et al. 2014; Rygula et al. 2014)
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being punished 25% of the time. Pessiglione et al. also inter-
leaved such discrimination trials with other trials using a dif-
ferent pair of distinctive icons that were associated with
avoiding losses instead of gaining rewards. They reported
significant differences in reinforcement learning between the
two DA manipulations, associated with alterations in BOLD
prediction error signals in specific DA terminal regions. Under
L-dopa treatment, subjects accrued more rewards during learn-
ing than under haloperidol, although there were no effects on
losses. By using the striatal BOLD responses to estimate pre-
diction errors, these authors were able to show that the drug
effects on behavioural choice conformed to a standard action–
value computational model of reinforcement learning (see Fig.
1 of Pessiglione et al. 2006 and Box 1). This included the
standard parameters of learning rate (α) and ‘temperature’
(β), adjusted to maximise the likelihood of the actual choices
of the subjects under the model.
This elegant demonstration naturally raises several issues,
including the pharmacological specificity of the agents
employed, the contribution of individual differences, and the
precise functional interpretation of parameters such as β
(temperature) which could, for example, reflect motivational
factors or general strategic tendencies such as ‘win-stay and
lose-shift’ or ‘exploration vs exploitation’ (e.g. the overall ratio
of stay to shift responses) (Cohen et al. 2007; Frank et al. 2009).
A problem we have observed, especially in human studies,
is the difficulty of performing dose-response studies,
particularly at low doses of certain agents that may affect
presynaptic ‘autoreceptors’ that regulate neurotransmitter
function and thus may actually lead to opposite functional
effects to those anticipated. For example, DA D2
autoreceptors inhibit DA neuronal firing and DA release from
dopaminergic neurons; thus, DA D2 antagonists can increase
DA release via presynaptic (autoreceptor) mechanisms (see
Ford 2014). Support for Michael Frank’s modelling of D2
receptor actions has depended to some extent on interpreting
the effects of haloperidol as working in part at DA D2
autoreceptors (e.g. Frank and O’Reilly 2006). Recently, we
were able to report tri-phasic effects of intra-caudate
quinpirole on reversal learning in monkeys, with low and high
doses impairing performance and intermediate doses signifi-
cantly improving learning (in terms of errors to criterion)
(Horst et al. 2019). We have also observed sometimes ‘para-
doxical’ improvements in cognitive performance of highly
selective D2/3 receptor antagonists such as sulpiride (Mehta
et al. 1999). Later studies by Mehta et al. (2008) showed that
the commonly used dose of 400 mg sulpiride occupies only
about 30% of striatal D2 receptors. Therefore, in the study of
Eisenegger et al. (2014), we obtained ethical permission to
administer a dose of 800 mg to healthy volunteers, which
occupies about 60% of striatal D2 receptors (and which in fact
produced no adverse side effects). We could therefore be fairly
sure that any presynaptic effects at the mid-brain level would
be overcome by the large D2 striatal receptor blockade (al-
though note there are also striatal D2 terminal autoreceptors
that may exert additional effects). We reduced variability
when assessing effects of drug dose by capitalising on indi-
vidual differences in plasma levels of the drug. Moreover,
based on previous behavioural findings relating genetic poly-
morphisms to learning parameters, including reversal (Frank
et al. 2007; Jocham et al. 2009; den Ouden et al. 2013), we
also stratified the population of human volunteers by
recruiting individuals with and without the DA D2 receptor
Taq1A polymorphism, as the minor A1 allele has been asso-
ciatedwith a reduction of up to 30% of striatal DAD2 receptor
density (Thompson et al. 1997). This stratification also poten-
tially helped to dissect possible D2 versus D3 receptor
influences.
Sulpiride had very clear-cut effects that were similar in
several ways to those of haloperidol in the study by
Pessiglione et al. (2006). There were effects on appetitive
but not aversive learning, possibly consistent with Schultz’s
findings in monkeys (Schultz et al. 1997). Notably, the drug
impaired performance, but its effects mainly appeared to be at
asymptotic levels of discrimination rather than in its initial
acquisition. In fact, this is again similar to the effects reported
by Pessiglione et al. Whilst the effects in the entire sample of
volunteers were statistically marginal, the findings did reach
significance when the influence of dose was introduced (low
versus high plasma levels of sulpiride) and there was also a
Fig. 1 Typical visual stimuli and reinforcement contingencies employed
for human studies of probabilistic learning and reversal in discrete trial
procedures involving forced choices between option A and option B.
Participants are instructed to obtain the most rewards as possible (best
achieved here by choosing exclusively the 75% rewarded stimulus).
Rewarding outcomes are denoted by brief immediate feedback from the
happy face presentation, and punishing outcomes by the frowning face.
Following attainment of a learning criterion over a suitable number of
trials, the contingencies may be reversed without warning. Such
paradigms can be employed to model reinforcement learning in humans
and experimental animals. The actual probabilities of reinforcement may
vary from study to study. Taken from Cools et al. (2002)
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genetic influence whereby the volunteers with the A1 poly-
morphism exhibited the largest effects.
All of these findings were further confirmed by the use of a
‘softmax’ Q-learning algorithm similar to that used by
Pessiglione et al. (2006) (Box 1), which showed that the ef-
fects were confined largely to the temperature parameter β
(Fig. 2). This precision achieved by the computational model
of the drug effects is impressive and has exciting implications,
although we are left to interpret what the effects on tempera-
ture (β) mean. One possibility is that the parameter reflects
‘exploration’ (versus ‘exploitation’) of the reinforcement con-
tingencies (Cohen et al. 2007). From a computational perspec-
tive, exploration versus exploitation has been related to chang-
es in tonic DA function in the basal ganglia (Humphries et al.
2012) and from genetic evidence in humans, exploration has
been shown to be affected by polymorphisms of the enzyme
catechol-O-methyl transferase, which regulates DA in the hu-
man prefrontal cortex (Frank et al. 2009).
The lack of effect on learning rate is perhaps surprising in
view of the presumed role of dopamine in learning. However,
it should not be forgotten that D2 receptors have been linked
with tonic rather than phasic modes of dopamine function and
that the prediction errors are supposed to be a function of the
latter (Dreyer et al. 2010). One hypothesis that emerges from
the findings is that the D1 DA receptor may be more directly
implicated in learning rate (parameter α). Unfortunately, D1
DA receptor antagonists have not been widely used in human
psychopharmacology to date due to the difficulty in obtaining
them for studies in healthy volunteers. However, there is a
clear prediction that D1 agents would affect α. Such a result
would also validate the sensitivity of the probabilistic learning
paradigm employed by Pessiglione et al. (2006) and
Eisenegger et al. (2014), which may possibly be more sensi-
tive to effects on β than α.
Computational modelling applied to a dopaminergic
animal model of schizophrenia
A second example of the use of computational approaches to
understanding effects on learning of dopamine manipulation
comes from an attempt to determine the functional sequelae of
DA depletion from the prefrontal cortex in marmoset mon-
keys (Clarke et al. 2014) to model some of the presumed
changes occurring in schizophrenia, which have been pro-
posed to reflect a reciprocal balance between cortical DA un-
deractivity and subcortical DA over-activity (Weinberger
1987; Meyer-Lindenberg et al. 2002). This focuses attention
on prefrontal cortical D1 receptors which have been reported
to be upregulated in unmedicated schizophrenia and may re-
flect a compensatory response to disorder-related down-regu-
lation of prefrontal DA (Abi-Dargham et al. 2012).
The experimental depletion in marmosets was effected by
6-hydroxydopamine and restricted to the orbitofrontal cortex.
Studies using ligand-based positron emission tomography
(PET) showed that this treatment caused a reduction of striatal
D2 receptor availability consistent with a striatal upregulation
of DA function. The monkeys were tested behaviourally using
a range of instrumental probabilistic visual discrimination
tasks, structurally similar to that employed for the human
studies described above. They were trained to respond to
two multi-coloured abstract shapes presented on a touch-
sensitive screen. One of these stimuli was probabilistically
rewarded with fruit juice, e.g. 80% of trials, whereas the other
was only rewarded 20% of the time. Negative feedback (20%
0.0
0.1
0.2
0.3
0.4
gain loss gain loss
α β
Placebo
Sulpiride
a          Sulpiride main effects
gain loss gain loss
α β
≤ 426 ng/ml
> 426 ng/ml
b     Serum level effects
gain loss gain loss
α β
Placebo
Sulpiride
c   Genotype effects (A1+)
Fig. 2 Effects of sulpiride on reinforcement learning model parameters in
human volunteers. Effects were restricted to ‘temperature’ (β) rather than
learning rate (α), were for gains only, and were exaggerated by higher
plasma levels of sulpiride and in participants with the A1+ genotype of
the Taq1A polymorphism for DA D2 receptors. Parameter estimates of
the Q-learning model were derived across drug, serum value and
genotype groups, separately for the gain and loss domain. a The
temperature parameter βgain was significantly higher in the sulpiride
group (57% increase compared to the placebo, P = 0.005), but the
learning rate αgain was not affected, and there were no effects in the loss
domain (αloss, βloss). b Higher sulpiride serum values selectively affected
the temperature parameter gain (183% increase in high compared to low
serum values, P = 0.001), with no effects on either αgain, αloss or βloss. c
Pronounced sulpiride effects on βgain were observed in A1+ genotype
carriers (211% increase following sulpiride compared to placebo
administration, P < 0.001), but not in A1–genotype carriers.
Reproduced from Eisenegger et al. (2014) with permission of the
publishers
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and 80%) was provided by aversive white noise. Thus the
reinforcement contingencies were quite similar to those
employed by Eisenegger et al. (2014) and Pessiglione et al.
(2006), above. The optimal strategy in such a discrimination is
of course to respond exclusively to the ‘majority’ reinforced
stimulus, i.e. 80%. This does mean that the marmoset has to
remember the overall associative strengths associated with its
choices and ignore, for example, occasional punishment for
responding to the 80% stimulus, and occasional reward asso-
ciated with the ‘minority’ (20%) stimulus. Disproportionate
reactivity to such immediate feedback, e.g. to shift away from
the majority stimulus following ‘spurious’ punishment, or to
stay with the minority stimulus following ‘spurious’ reward,
would both serve to retard overall learning. Thus, the rein-
forcement contingencies in this task can be described as occa-
sionally being ‘misleading’ and affecting their overall ‘truth-
fulness’ or ‘falsity’, i.e. ‘veracity’, with respect to the overall
discrimination task.
Bearing in mind these subtle contingencies, the behaviour-
al changes caused by OFC DA depletion were quite complex
and initially difficult to characterise. The OFC DA depleted
monkeys were faster to learn, i.e. they made fewer errors to
criterion than sham-operated controls. More detailed analysis
revealed that this was because the OFCDA depleted monkeys
were less affected by ‘false’ punishment, so that they more
rapidly discriminated the 80% reinforced, majority stimulus
with fewer shifts to the 20% reinforced, minority stimulus.
The OFC DA depleted monkeys were not though less sensi-
tive to ‘true’ punishment. Deeper analysis however revealed
some difficulties with this simple formulation. Although the
effect clearly depends on the prior history of outcomes, when
behaviour was analysed for dependencies further back in the
sequence of trials (n-back), also taking into account apparent
stimulus preferences of the monkeys, this failed to provide a
satisfactory description of their behavioural choices.
Therefore, in order to gain further understanding of this
change in behaviour, it was characterised further using com-
putational reinforcement learning models. Two major classes
were considered. The first was termed ‘model-based’ (or ‘de-
clarative’) learning, in which the subjects are assumed to have
expectancies about outcomes and track the reinforcement
probabilities with varying degrees of certainty, based on in-
corporating the current evidence into their prior estimates of
them. Thus an ‘ideal subject’would estimate the overall prob-
ability of reinforcement for each stimulus (utilising logical
inference to update the associative strengths or values of both
stimuli on each trial rather than simply focusing on one stim-
ulus), represent its uncertainty about those estimates, and
choose so as to maximise the reward obtained. The subject
might in principle have elaborate hypotheses about the struc-
ture of the task, for example, anticipating when reversals may
occur on the basis of sequences of trial outcomes. This is
essentially an ‘optimal Bayesian’ class of models.
The second class of models was described as being ‘model-
free’ (the animal does not form a ‘model’ or declarative set of
expectations about the environment) and depends on simple
reinforcement rules. Value-based delta reinforcement learning
algorithms simply assign a value to each stimulus or action in
a single update manner, and choose accordingly; the values
are updated according to rules and parameters determining the
impact of reward or punishment (e.g. sensitivity to reward or
punishment, or to reinforcement in general). There is thus no
overall strategy for representing the environment as a whole.
Some additional parameters were also defined. One of these
was the tendency to prefer one stimulus over the other, irre-
spective of its reinforcement contingencies—i.e. the likeli-
hood of repeating a choice of that stimulus, or ‘stimulus stick-
iness’. The second was an analogous tendency to prefer one
response location because it had been chosen on the previous
trial (‘side stickiness’). Consideration of these local strategic
tendencies appeared likely to explain some of the behavioural
choices of the marmoset, as had earlier been acknowledged by
the type of analysis advocated by Sahgal and Clincke (1985)
described above. Full computational details of these two clas-
ses of model can be found in Clarke et al. (2014).
Thus, several different models were formulated for the be-
havioural data and tested against one another for the best fit to
the data using a standard method called the Bayesian
Information Criterion (BIC), which takes into account such
factors as the number of parameters employed (fewer being
better). (Statistical methods move on, and more recent work
has improved the optimal method for Bayesian model
comparison; see Gronau et al. 2017.) The ‘winning’, simple
reinforcement learningmodel (Box 1) included parameters for
(1) sensitivity to overall reinforcement, regardless of valence,
(2) stimulus stickiness and (3) side stickiness. OFC DA deple-
tion modulated the model’s parameters, affecting both rein-
forcement sensitivity and local response strategies.
Specifically, it reduced side stickiness and increased reinforce-
ment sensitivity (irrespective of whether for reward [gain] or
punishment [loss]). Of these two effects, the latter was most
important for simulating the observed reduction of errors to
criterion and was also found to correlate negatively with D2
receptor binding in the head of the caudate nucleus (but, im-
portantly, not in the OFC itself). This reduction in errors could
be inferred to correlate with increased DA levels in the head of
the caudate. By contrast, the side stickiness parameter corre-
lated better with D2 receptor binding in the body of the cau-
date, which is consistent with the role of the dorsal striatum in
egocentric spatial processing (e.g. Brasted et al. 1997).
These results lead to several interesting implications. First,
they are consistent with a view that striatal DA changes are not
only important for reinforcement learning, but additionally may
affect local strategies such as side bias, probably via effects on
striatal tonic levels (as the OFC DA depletion did not affect
phasic striatal DA release, determined by microdialysis of this
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region with K+ pulses). The reduced side bias may even reflect
an increased tendency to ‘exploration’ (c.f. Cohen et al. 2007),
analogous to effects of systemic d-amphetamine to increase
response switching in an uncertain environment (Evenden
and Robbins 1983) and also to the strategies of acute psychotic
patients exposed to a random 2-choice guessing game (Frith
and Done 1983). Indeed, other studies of patients with schizo-
phrenia using a similar probabilistic reversal learning procedure
(e.g. Waltz and Gold 2007; Waltz et al. 2007, 2013;
Schlagenhauf et al. 2014) have also shown changes in param-
eters of reinforcement learning, illustrating the translational po-
tential of this approach. Specifically, medicated first episode
patients with schizophrenia exhibit probabilistic reversal learn-
ing as an apparent consequence of increased switching and
impaired reinforcement sensitivity (Waltz et al. 2013). Whilst
D2 receptor antagonists certainly affect probabilistic reinforce-
ment learning parameters in healthy volunteers, as we have
described above, the study by Schlagenhauf et al. 2014) con-
firmed that the behavioural deficits in probabilistic reversal
were also present in unmedicated patients with schizophrenia.
The latter study also showed that it was feasible to use compu-
tational modelling to identify individual differences in how
patients may approach tests such as probabilistic reversal and
thus provide a basis for stratification that may help to resolve
heterogeneity in clinical populations.
Computational modelling applied to a serotoninergic
translational model of affective disorder
The probabilistic (reversal) learning paradigm has also been
used in the context of defining certain deficits in depression.
Apart from the relevance of changes in reinforcement learning
in this patient group, some early studies noted a particularly
relevant effect that may relate directly to certain symptoms in
depression associated with Beck’s ‘negative set’—the tenden-
cy to focus on negative aspects of experience. Thus, Murphy
et al. (2003) reported that patients with major depressive dis-
order exhibited a significant tendency to shift responding after
negative feedback. Whilst this may appear to be a normal
consequence of Thorndike’s (1898) Law of Effect (see
Thorndike 1911), it is clearly disadvantageous in certain cir-
cumstances when, as in the 80:20 reinforcement contingency
for the ‘majority’ stimulus, it is appropriate to stay after a loss
or negative feedback rather than to shift. This aberrant shifting
behaviour is obviously disadvantageous and was later shown
to occur in unmedicated patients with depression in an fMRI
setting, where it was correlated with the absence of a deacti-
vation in the amygdala that usually occurs in control subjects
in this task (and also with a possibly regulatory absence of a
prefrontal cortical activation that hypothetically regulates this
amygdaloid response) (Taylor Tavares et al. 2008).
Other studies have focused on possible neurochemical cor-
relates of this apparently heightened reactivity to negative
feedback, specifically mediated by serotonin—guided by the
fact that depression often responds to selective serotonin re-
uptake inhibitors (SSRIs) (Anderson et al. 2008). These ef-
fects of medication are a major source of evidence in support
of the serotoninergic hypothesis of depression, which has
some additional limited support from PETstudies of the status
of 5-HT receptors and the 5-HT transporter in major depres-
sive disorder (e.g. Reimold et al. 2008; Kaufman et al. 2015).
Chamberlain et al. (2006) reported that low doses of the SSRI
citalopram impaired performance on a probabilistic learning par-
adigm in healthy volunteers. Skandali et al. (2018) recently
followed up these findings in a similar group of volunteers to
show increased shifting in response to negative feedback.
In order to test these effects more mechanistically in a ro-
dent model, Bari et al. (2010) designed a spatial version of the
probabilistic reversal task in which reinforcement was
assigned according to 80:20 and 20:80 contingencies. Dose-
related effects of both acute and sub-chronic citalopram were
investigated. Effects of central depletion of 5-HT were also
determined following intra-ventricular application of 5,7-
dihydroxytryptamine, leading to profound forebrain 5-HT
loss. The main findings are summarised in Table 1. As can
be seen, the effects of an acute low dose (1 mg/kg) and high
(10 mg/kg) dose were almost opposite in direction.
Importantly, the acute low dose simulated what has been
shown human studies, i.e. increased lose-shift behaviour that
interferes with the number of reversals achieved, whereas the
acute high dose (which presumably produces a net increase in
5-HT transmission via its effects on the 5-HT transporter)
improved overall performance. Interestingly, repeated or
sub-chronic citalopram also improved reversal performance
although via increased win-stay rather than reduced lose-
shift behaviour, suggestive of some other neurochemical ac-
tion. Finally, profound depletion of forebrain 5-HT produced a
pattern of findings that resembled acute low-dose citalopram.
Overall, these findings are consistent with the human findings,
but they do not identify the neural loci at which these effects
occur.
Functional brain imaging studies of the probabilistic learn-
ing and reversal task have implicated fronto-striatal systems as
well as the amygdala (Cools et al. 2002; Pessiglione et al.
2006; Taylor Tavares et al. 2008). Therefore, in a study by
Rygula et al. (2014), we focused on effects of regional 5-HT
depletion (via 5,7-dihydroxytrypamine) of the amygdala and
orbitofrontal cortex in marmosets, using a form of the visual
probabilistic reversal task employed byClarke et al. (2014) for
studying effects of orbitofrontal DA depletion.
These treatments, which produced up to 80% local deple-
tion of 5-HT within about a month after surgery, had behav-
ioural effects analogous to those seen in the human studies. 5-
HT depletion in the amygdala impaired performance on the
visual probabilistic reversal by increasing the effectiveness of
‘misleading’ negative feedback. OFC 5-HT depletion had
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similar (but only trend level) effects. However, computational
modelling during the learning phase found, perhaps surpris-
ingly, that the behavioural data for that stage in both sites
could be accounted for with a relatively simple delta rule
reinforcement learning model, similar to that used in Clarke
et al. (2014) for the orbitofrontal DA depletion experiment
described above. The effects on probabilistic learning could
mainly be explained by reductions in reinforcement sensitivity
(operating similarly for reward and punishment), both for 5-
HT depletion of the amygdala and for the weaker effects ob-
served for the orbitofrontal cortex. However, increased ‘stim-
ulus stickiness’ (i.e. the tendency to repeat responding to the
same visual stimulus, regardless of feedback; Box 1) also
offered a potential explanation of some of the data at the latter
site, whereas the amygdala 5-HT depletion tended to have
opposite effects on stimulus stickiness. These models were
generated and tested in the same way as before; the final test
was to determine to what extent they could simulate the orig-
inal behavioural data (Fig. 3).
In this example, computational modelling has not fully vin-
dicated the analysis that manipulation of 5-HT function specif-
ically enhances effect of misleading negative feedback in fa-
vour of a more general detrimental action on reinforcement.
This needs to be resolved by further experiments and
analysis. It was not feasible to apply the computational model
to the reversal phases in Rygula et al. (2014) because of the
relative lack of data and the well-known problem of ‘over-
fitting’ the model. The modelling does raise the possibility that
not only is the impact of false negative feedback affected by 5-
HT, but also that of false positive feedback—in other words, is
the tendency to repeat rewarded responses for the minority
stimulus also increased? This parameter has not previously
been analysed, e.g. in the study of Bari et al. (2010) or the
clinical studies, generally because these events did not occur
at sufficient frequency.
On the other hand, the effect of orbitofrontal 5-HT deple-
tion may be compatible with a number of other findings.
Seymour et al. (2012) found that acute dietary tryptophan
depletion in healthy human volunteers tended to increase stim-
ulus stickiness, and the findings may also contribute to our
understanding of the effects of orbitofrontal 5-HT loss on
deterministic visual reversal learning in marmosets (Clarke
et al. 2004). A parallel modelling project has been analysing
the performance of patients with obsessive-compulsive disor-
der (OCD) and stimulant drug dependence on the visual prob-
abilistic reversal learning task, finding opposite effects, for
Table 1 Effects of 5-HT manipulations on probabilistic spatial reversal in rats
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example, on stimulus stickiness (greater in stimulant depen-
dence, but reduced in OCD) (Kanen et al. 2019). These ex-
amples provide considerable hope that it may ultimately be
feasible to generalise findings of effects of neurotransmitter
manipulations from experimental animals (rodent and mon-
keys) to humans, including patients, and the effects of medi-
cations in a new translational agenda that utilises computa-
tional modelling as a unifying strategy for reducing differ-
ences among experimental test paradigms and allowing gen-
eralisations at a more theoretical level.
Model-based versus model-free learning
Most of the modelling we have performed thus far on data
from experimental animals has found that rather simple,
reinforcement-based models have proven adequate to account
for the data rather than the more representationally elaborate
‘model-based’ learning now increasingly used to characterise
human performance. The two-stage Markov decision-making
task introduced by Daw (2011) enables a direct comparison to
be made of effects of drugs or neurochemical manipulations
on model-based versus model-free learning, in the same indi-
vidual. A full description of the task and its rationale is pro-
vided elsewhere (Daw 2011). In general, it has some affinities
with the simpler probabilistic learning in that it is sometimes
optimal to resist the usual urges to repeat successful choices
and to shift from unsuccessful ones, in order to maximise
reinforcement. This task has increasingly been employed to
make comparisons between patient groups and healthy con-
trols, commonly finding that there is a shift towards model-
free learning, for example in stimulant dependence or OCD
(e.g. Voon et al. 2015). Pharmacological studies are at present
at an earlier stage, however. Wunderlich et al. (2012) reported,
perhaps surprisingly, that a dose of L-DOPA selectively en-
hanced model-based learning, perhaps as a consequence of its
actions in the ventral striatum (Deserno et al. 2015). Had it
been ethically permissible to employ higher doses, these may
have alternatively had effects on model-free behaviour via the
dorsal striatum. Worbe et al. (2016) modified the task to in-
clude a parallel set of contingencies to avoid loss (in addition
to the usual ones for gain) and studied the effects of acute
dietary tryptophan depletion. This treatment had striking ef-
fects on model-based versus model-free learning that
depended on affective valence. Tryptophan depletion en-
hanced model-free processing when it was appetitive, but
model-based performance when aversive. This strongly sug-
gests again that a manipulation of 5-HT can have asymmetri-
cal effects on reward and aversive processing, as suggested by
the original observations on patients with depression (Murphy
et al. 2003) and some of the pharmacological studies of 5-HT
function. We can anticipate further studies with these evolving
test procedures to be made with more precise neurobiological
interventions in experimental animals.
Summary and conclusions
‘Computational psychopharmacology’, like computational psy-
chiatry (Heinz 2017), is a young and nascent field that seems
to be worthy of further development, especially in a transla-
tional context that links the two. We have summarised recent
findings from a specific set of test paradigms based around
probabilistic learning and reversal learning that show some
promise in uncovering new principles about drug or neuro-
chemical effects, of possible relevance to pharmacotherapeutics.
However, rather than merely describing behavioural effects of
Fig. 3 Retrodicting actual
behavioural data in probabilistic
learning by marmoset monkeys
by the ‘winning’ (best-fitting)
reinforcement learning model
(right). Open squares, sham-
operated group. Filled circles,
amygdala 5-HT depleted group.
Filled triangles, orbitofrontal 5-
HT depleted group. The
amygdala 5-HT depleted group
exhibited impairments in
responding to both ‘misleading’
and ‘truthful’ feedback, which
were accurately modelled as a
deficit in reinforcement
sensitivity. Reproduced from
Rygula et al. (2014)
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drugs, the emergent models will also have to make contact
with plausible psychological constructs, explain psychiatric
symptoms, and make testable predictions for other test settings
and situations, in order for them to become fully pragmatic and
paradigmatic.
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